First-pass extracted concept

retinal prostheses

Candidate: concept label2 source documents2 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

including non-invasive drug delivery, theranostic contrast agents, therapeutic nanoagents, gene therapy, stem cell-based therapy, retinal optogenetics and retinal prostheses

Evidence 1Source 1DOI PubMedprovenance

While gene therapy, optogenetic tools, photosensitive switches, and retinal prostheses offer hope for vision restoration, these high-cost therapies will benefit few patients.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review2024Progress in Retinal and Eye ResearchDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1scope statementsupports2025Source 1DOI PubMed

The paper reviews retinal nanomedicine applications including non-invasive drug delivery, theranostic contrast agents, therapeutic nanoagents, gene therapy, stem cell-based therapy, retinal optogenetics, and retinal prostheses.

Claim 2cost access summarysupports2024Source 2DOI PubMed

Gene therapy, optogenetic tools, photosensitive switches, and retinal prostheses are described as high-cost vision restoration therapies that will benefit few patients.